期刊文献+

T 波峰-末间期与Brugada综合征危险分层的相关性研究 被引量:8

Tpeak-Tend interval and risk of cardiac events in patients with Brugada syndrome
原文传递
导出
摘要 目的评价普通体表心电图 T 波峰-末间期(Tpeak-Tend,Tp-e)作为 Brugada 综合征(Brs)一种新的危险分层指标。方法将23例男性 BrS 患者与20例男性阵发性室上性心动过速(PSVT)患者的体表心电图 Tp-e 值进行比较。结果 Tp-e 平均值,BrS 组为(109.57±22.86)ms,PSVT 组为(88.50±13.08)ms,两组间差异有统计学意义(P<0.05)。BrS 组中16例患者并发心脏事件(晕厥、临床记录心室颤动、电生理诱发心室颤动),7例患者无上述心脏事件,心脏事件组的 BrS 患者 Tp-e 值较无心脏事件组 BrS 患者和 PSVT 组患者显著延长(P<0.05),而无心脏事件组 BrS 患者与PSVT 组患者 Tp-e 值间差异无统计学意义(P>0.05)。结论 Tp-e 值延长(Tp-e≥120 ms)可作为BrS 患者一种新的无创性危险分层指标。 Objective To evaluate the possible association between Tpeak-Tend (Tp-e) interval in surface standard ECG and cardiac events in patients with Brugada syndrome (BrS). Method Tp-e interval in surface standard ECG was compared between BrS patients (n = 23, all males ) and paroxysmal supraventricular tachycardia (PSVT) patients (n = 20, all males) as well as between BrS patients with (n = 16) or without (n = 7) cardiac events. Results There was significant difference in Tp-e interval between BrS patients and PSVT patients [ ( 109. 57 ± 22. 86) ms vs. ( 88.50 ± 13.08 ) ms, P 〈 0. 05 ]. Tp-e interval was also significantly longer in BrS patients with cardiac events ( syncope, clinical ventricular fibrillation and induced VF during electrophysiological study) than BrS patients without cardiac events [ (118.12 ± 20.40 ) ms vs. (90. 00 ± 15.27) ms, P 〈0. 05 ] while Tp-e interval was similar between BrS patients without cardiac events and PSVT patients ( P 〉 0. 05 ). Conclusion The prolongation of Tp-e ( ≥ 120 ms) was associated with higher cardiac events in BrS patients.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2007年第7期629-632,共4页 Chinese Journal of Cardiology
基金 国家自然科学基金(30570746) 南京医科大学创新基金(CX2003015)
关键词 心室颤动 危险因素 BRUGADA综合征 Ventricular fibrillation Risk factors Brugada syndrome
  • 相关文献

参考文献12

  • 1Brudaga P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death : a distinct clinical and electracar diographic syndrome. A multicenter report. J Am Coll Cardiol, 1992,20 ( 6 ) : 1391-1396.
  • 2Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: report of the second consensus conference. Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation ,2005,111( 5 ) :659 -670.
  • 3单其俊,杨兵,曹克将,陈明龙,李库林,陈椿,邹建刚,王卫明,王小斌,朱品军,徐东杰.新胸导联在诊断Brugada综合征中的应用[J].中华心血管病杂志,2004,32(7):578-583. 被引量:15
  • 4李库林,杨兵,单其俊,陈明龙,徐东杰,曹克将.应用普罗帕酮激发试验对Brugada综合征七例患者的诊断价值[J].中华心律失常学杂志,2004,8(6):335-339. 被引量:14
  • 5Wilde AA, Antzeleviteh C, Borggrefe M, et al. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation ,2002,106 ( 19 ) :2514-2519.
  • 6Xia Y, Liang Y, Kongstad O, et al. Tpeak-Tend interval as an index of global dispersion of ventrieular repolarization : evaluations using monophasic action potential mapping of the epi- and endocardium in swine. J Interv Card Electrophysiol,2005,14 (2) : 79-87.
  • 7Sicouri S, Antzelevitch C. A subpopulation of cells with unique electrophsiology properties in the deep subepicardium of the canine ventricle: the M cell. Circ Res, 1991,68(6) :1729-1741.
  • 8Fish JM, Di Diego JM, Nesterenko V, et al. Epieardial activation of left ventrieular wall prolongs QT interval and transmural dispersion of polarization : implications for biventrieular pacing. Crieulation ,2004,109 ( 17 ) :2136-2142.
  • 9Medina-RaveU VA, Lankipalli RS, Yan GX, et al. Effect of epieardial or biventrieular pacing to prolong QT interval and increase transmural dispersion of repolarization : does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes? Circulation, 2003,107 ( 5 ) : 740- 746.
  • 10Castro Hevia J, Antzeleviteh C, Tomes Barzaga F, et al. Tpeak- Tend and Tpeak-Tend dispersion as risk factors for ventrieular taehyeardia/ventrieular fibrillation in patients with the Brugada syndrome. J Am Coll Cardiol,2006,47(9) :1828-1834.

二级参考文献16

  • 1Antzelevitch C, Brugad P, Brugada J, et al. Brugada syndrome: 1992-2002, a historical perspective. J Am Coll Cardiol,2003,41:1665-1671.
  • 2Sangwatanaroj S, Prechawat S, Sunsaneewitayakul B, et al. Right ventricular electrocardiographic leads for detection of Brugada syndrome in sudden unexplained death syndrome survivors and their relatives. Clin Cardiol,2001,24:776-781.
  • 3Eckardt L, Bruns HJ, Paul M, et al. Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome. J Cardiovasc Electrophysiol,2002,13:742-749.
  • 4Wilde AAM, Antzelevitch C, Borggrefe M, et al. Proposed diagnostic criteria for the brugada syndrome consensus report. Circulation, 2002, 106:2514-2519.
  • 5Potet F, Mabo P, Coq G, et al. Novel Brugada SCN5A mutation leading to ST segment elevation in the inferior or the right precordial leads. J Cardiovasc Electrophysiol, 2003,14:200-203.
  • 6Rolf S, Bruns HJ, Wichter T, et al. The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol. Eur Heart J,2003,24:1104-1112.
  • 7Matana A,Goldner V,Stanic K,et al. Unmasking effect of propafenone on the concealed form of the Brugada phenomenon. PACE,2000,23:416- 418.
  • 8Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia mechanism. J Cardiovasc Electrophysiol,2001,12:268-272.
  • 9Akdemir I,Davutoglu V,Aksoy M. Intermittent Brugada syndrome misdiagnosed as acute myocardial infarction and unmasked with propafenone. Heart,2002,87:543.
  • 10Maury P,Couderc P,Delay M,et al. Electrical storm in Brugada syndrome successfully treated using isoprenaline. Europace,2004,6:130-133.

共引文献23

同被引文献63

引证文献8

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部